StockDuty ← Dashboard Oct 24, 2026 04:44 AM ET
SignalCorporate

$APVO (Aptevo Therapeutics) — 8-K: Aptevo extends rights agreement to October 23, 2027, sets purchase price at $14.56

APVO
$0.40
-2.37%
Aptevo Therapeutics entered Amendment No. 6 to its Rights Agreement on October 23, 2026, extending the Final Expiration Date to October 23, 2027. The amendment also changes the Purchase Price to $14.56 per one one-thousandth of a share of Series A Junior Participating Preferred Stock. The rights pertain to contingent rights to purchase fractional Preferred Shares under the agreement with Broadridge Corporate Issuer Solutions, LLC as rights agent.
Aptevo Therapeutics entered Amendment No. 6 to its Rights Agreement on October 23, 2026, extending the Final Expiration Date to October 23, 2027. The amendment also changes the Purchase Price to $14.5
Sources